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Purpose: Report the radiographic and magnetic resonance imaging (MRI) structural outcomes of an
18-month study of diet-induced weight loss, with or without exercise, compared to exercise alone in
older, overweight and obese adults with symptomatic knee osteoarthritis (OA).
Methods: Prospective, single-blind, randomized controlled trial that enrolled 454 overweight and obese
(body mass index, BMI ¼ 27e41 kg m2) older (age  55 yrs) adults with knee pain and radiographic
evidence of femorotibial OA. Participants were randomized to one of three 18-month interventions: diet-
induced weight loss only (D); diet-induced weight loss plus exercise (D þ E); or exercise-only control (E).
X-rays (N ¼ 325) and MRIs (N ¼ 105) were acquired at baseline and 18 months follow-up. X-ray and MRI
(cartilage thickness and semi-quantitative (SQ)) results were analyzed to compare change between
groups at 18-month follow-up using analysis of covariance (ANCOVA) adjusted for baseline values,
baseline BMI, and gender.
Results: Mean baseline descriptive characteristics of the cohort included: age, 65.6 yrs; BMI 33.6 kg m2;
72% female; 81% white. There was no signiﬁcant difference between groups in joint space width (JSW)
loss; D 0.07 (SE 0.22) mm, D þ E 0.27 (SE 0.22) mm and E 0.16 (SE 0.24) mm (P ¼ 0.79). There was
also no signiﬁcant difference in MRI cartilage loss between groups; D 0.10(0.05) mm,
D þ E 0.13(0.04) mm and E 0.05(0.04) mm (P ¼ 0.42).
Conclusion: Despite the potent effects of weight loss in this study on symptoms as well as mechanistic
outcomes (such as joint compressive force and markers of inﬂammation), there was no statistically
signiﬁcant difference between the three active interventions on the rate of structural progression either
on X-ray or MRI over 18-months.
© 2015 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved..joca.2014.12.027.
: D.J. Hunter, Rheumatology
Clinical School, University of
Fax: 61-2-9463-1077.
Hunter).
ternational. Published by Elsevier LIntroduction
Obesity is the single most important risk factor for development
of severe osteoarthritis (OA) of the knee1e3. Because obesity is both
a risk factor for OA and has been increasing in prevalence over the
past four decades4,5, it is projected that substantially moretd. All rights reserved.
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being a leading risk factor for knee OA incidence, obesity also
contributes directly towards the genesis of symptoms7.
Weight reduction has demonstrated the ability to decrease
the pain and disability associated with knee OA8,9. Recent meta-
analyses conclude that a >5% reduction in weight will result in
moderate-to-large improvements in self-reported disability10.
Similarly, exercise also leads to improvement in self reported
symptoms11 and in trials does not appear to harm structure8
despite recent observational evidence that it may12. Mechanis-
tically, weight reduction may lead to reductions in joint loads and
inﬂammatory cytokines9, and this may be helpful in preserving
joint integrity; or at least not leading to more rapid decline as a
consequence of increased walking speed and knee joint
loading13. However, despite solid clinical evidence supporting the
efﬁcacy of weight loss for symptom improvement, there is
limited evidence from existing studies on the effects of weight
loss on articular tissue structures; and to date few of these
studies have actually been on persons with deﬁnite OA14,15. Ding
et al.16 demonstrated that excess body fat was associated with
greater tibial cartilage loss, and that a greater percentage of lean
mass was protective. This study raises important concerns that in
the absence of preserving lean mass, weight loss may not be
beneﬁcial for preserving joint structures. Further reinforcing the
potential concerns of weight loss, large weight loss in morbidly
obese persons initiates a faster gait which would tend to increase
knee loads or at least partially attenuate the reduction in knee
loads17. An observational trial of massive weight loss through
gastric surgery demonstrated marked improvements in cartilage
synthesis and reductions in cartilage degradation biomarkers14.
In an observational cohort of persons undertaking either non-
surgical or surgical intervention for weight loss, weight reduc-
tion was associated with improvements in cartilage composition
(proteoglycan content) and tissue loss (reduced cartilage thin-
ning) over 12 months18. More recently in a randomized trial in
obese persons with knee OA, investigators did not ﬁnd differ-
ences between exercise, diet and no attention groups for carti-
lage loss, synovitis or effusion on magnetic resonance imaging
(MRI)15. There was however a potentially increased number of
bone marrow lesions (BMLs) in the exercise group.
Given that weight loss reduces pain9, improves function, and
reduces knee joint loads, we hypothesized that weight loss would
also favorably alter the rate of structural progression in persons
with knee OA. Since there is a lack of well controlled data on the
effects of weight loss on joint structure, we undertook additional
analyses in an existing dataset from subjects who participated in
the recently reported Intensive Diet and Exercise for Arthritis
(IDEA) trial9. The intent of the present investigationwas to examine
the radiographic and MRI structural outcomes from IDEA; an 18-
month study of diet-induced weight loss, with or without exer-
cise, compared to exercise alone in older, overweight and obese
adults with symptomatic knee OA.
Materials and methods
Study design
IDEA was a single-blind, single-center, 18-month, randomized
controlled trial9,19. Participants were randomized into one of the
three groups: diet-induced weight loss only (D); diet-induced
weight loss plus exercise (D þ E); or exercise-only control (E). We
designated E as the comparison group because our previous work20
indicated that aerobic walking or resistance training should be part
of the standard-of-care for knee OA patients. The trial design,
rationale and primary outcomes are reported elsewhere9,19.Study oversight
IDEAwas conducted from July 2006 to June 2011 at Wake Forest
University and the Wake Forest School of Medicine, Winston-
Salem, NC, USA. It was HIPAA (Health Insurance Portability and
Accountability Act) compliant and approved by the Human Subjects
Committee of Wake Forest Health Sciences. Informed consent was
obtained from all study participants.Study sample
The IDEA study consisted of 454 ambulatory (a subsample of
325 persons had repeat X-rays and 105 had repeat MRIs for this
analysis), community-dwelling persons age  55 years with: (1)
KellgreneLawrence (KL) grade 2 or 3 (mild or moderate) radio-
graphic femorotibial OA or femorotibial plus patellofemoral OA of
one or both knees21, (2) pain on most days due to knee OA, (3)
27  body mass index (BMI)  41 kg m2, and (4) a sedentary
lifestyle (<30 min wk1 of formal exercise past 6 months). Partic-
ipants were recruited from the community over a 37-month period
(November 2006 to December 2009). A stratiﬁed-block randomi-
zation method was used to assign all eligible persons to one of the
intervention arms, stratiﬁed by BMI and gender.Interventions
a. Intensive weight loss intervention. Both the D and D þ E groups
received the same dietary intervention. The weight loss goal
was a mean group loss of at least 10% of baseline weight. The
dietary plan was based on partial meal replacements,
including up to two meal-replacement shakes per day (Lean
Shake®, provided by General Nutrition Centers, Inc., Pitts-
burgh, PA). For the third meal, participants followed a weekly
menu plan and recipes that were 500e750 kcals, low in fat
and high in vegetables. Daily caloric intake was adjusted ac-
cording to the rate of weight change between intervention
visits.
The initial diet plan provided an energy-intake deﬁcit of
800e1000 kcals/day as predicted by energy expenditure (esti-
mated resting metabolism  1.2 activity factor) with a minimum
of 1100 kcals for women and 1200 kcals for men. The calorie
distribution goal was 15e20% from protein, <30% from fat, and
45e60% from carbohydrates, consistent with the Dietary Refer-
ence Intakes for Energy and Macronutrients22 and successful
weight-loss programs23. As follow-up progressed, fewer meal
replacements were consumed. Body weight was monitored
weekly or biweekly during nutrition education and behavioral
sessions: these included from months 1e6, one individual ses-
sion and three group sessions per month, and from months 7e18,
biweekly group sessions and an individual appointment every 2
months.
b. Exercise. The exercise intervention was identical for E and D þ E.
Sixty-minute sessions were conducted 3 days/week for 18
months. During the ﬁrst 6 months, participation was center-
based. After 6-month follow-up (FU6) testing and a 2-week
transition phase, participants could remain in the facility pro-
gram, opt for a home-based program, or combine the two. The 3
days/week program consisted of aerobic walking (15 min),
strength training (20 min), a second aerobic phase (15 min), and
cool-down (10 min).
c. Intensive weight loss plus exercise. Participants randomized to the
Dþ E intervention received both interventions described above.
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X-ray acquisition and measurement
Bilateral, posteroanterior, weight-bearing, semiﬂexed, knee X-
rays were acquired at baseline and repeated at 18-month follow-up
(FU18) to assess changes in quantitative measures of radiographic
joint space width (JSW). All radiographs with paired acquisitions
(baseline and FU18) are included in this analysis (n ¼ 325). Par-
ticipants' knees were ﬂexed at 15 using a SynaFlexerpositioning
device (Synarc, San Francisco, CA), and the beam centered on the
joint space. The X-ray beam was directed perpendicular to the
cassette to pass between the femoral condyles and the patella
surfaces. The exact angle of the beam depends upon the degree of
ﬂexion of the knee and the participant's individual body habitus
and was adjusted between 0 and 15 under ﬂuoroscopy. The focus-
to-ﬁlm distance was held constant throughout the study. This
method of acquisition standardizes positioning to optimize
reproducibility24.
The minimum JSW (mJSW) was measured in digitized radio-
graphic images using an automated software application25e27.
Further, ﬁxed distances were measured between the external and
internal border of the medial femorotibial compartment (MFTC).
The software automatically determined the tangent to the femoral
condyles as the x-axis of the coordinate system; the medial and
lateral borders were marked manually, perpendicular to this x-axis
and tangential to the greatest prominence of the medial and the
lateral femoral epicondyles. After normalization of the range to
0 (medial epicondyle) and 1 (lateral epicondyle), ﬁxed locations
were deﬁned on the x-axis to obtain ﬁxed-location measures of
JSW, speciﬁcally JSW(x) between x ¼ 0.15 (external) and x ¼ 0.30
(internal) for MFTC27 (Fig. 1). Based upon superior responsiveness
from prior analyses we selected the JSWx ¼ 0.225 as the preferred
location for the ﬁxed coordinate JSW measure25.
Because even the above standardized positioning techniques
still have potential for malpositioning, positioning accuracy was
measured by examining the distance between the anterior and
posterior tibial rim. We deﬁned malpositioning as a change in this
distance of >2 mm between the baseline and FU18 radiograph.Full-length X-ray
A full-length AeP radiograph was obtained using the Agfa ADC
system (Quantum Q-Rad based imaging) approach. Participants
were positioned using the methods of Sharma et al.28 such thatFig. 1. Landmarks and deﬁnition of coordinate system.both lower extremities were imaged simultaneously. Both tibial
tubercles were faced directly forward and the participants' feet
were positioned 15 cm apart. Participants stood upright with
weight equally distributed to both feet. Alignment was deﬁned as
the measure of the angle formed by the intersection of the lines
connecting the centers of the femoral head and the intercondylar
notch and the centers of the ankle talus and tibial spines. A varus
knee was an angle >2 in the varus direction (or a bowlegged
appearance), and valgus was an angle < 2 in the valgus direction
(or a knock-kneed appearance). A neutral knee was deﬁned as an
angle between 2 and 2 in the varus direction29. All of the mea-
surements were made by a single physician and using the NIH
ImageJ program. Interrater reliability was 0.994.
MRI acquisition
MRI of the most symptomatic knee was performed on a sub-
sample of study participants with 105 (of 454 participants) having
both baseline and follow-up MRI scans acquired. Sample size per
group is as follows: (D) n ¼ 33, (D þ E) n ¼ 36, (E) n ¼ 36. This
subsample was randomly selected during the latter recruitment
waves of the study. MRIs were obtained with a 1.5 T (General
Electric Healthcare, Milwaukee, WI) scanner using an extremity
coil. The following MRI sequences were obtained: (1) Double
oblique coronal three-dimensional spoiled gradient-echo (SPGR)
with fat suppression; (2) Axial T1-weighted spin-echo (SE); (3)
Double oblique coronal T1-weighted SE; (4) Sagittal T1-weighted
SE; (5) Sagittal T2-weighted fast spin-echo (FSE) with fat sup-
pression; (6) Double oblique coronal T2-weighted FSE with fat
suppression.
Semi-quantitative (SQ) scoring of joint tissue structures. MRIs
were read paired and unblinded to timepoint by a musculo-
skeletal radiologist with 14-year experience in semiquantitative
MRI assessment and using the BLOKS method30. The following
MRI features were scored: (1) BML size; (2) BML Count; (3)
Synovitis; and (4) Effusion.
BML size was assessed over nine anatomical sites/subregions at
baseline and FU18. Outcomes for each subregion were classiﬁed
using the semiquantitative scale 0 ¼ “none”, 1 ¼ “<10%”,
2 ¼ “10e25%”, 3 ¼ “>25%”, where the % describes the proportion of
the subregion affected BMLs. We used a maximum scoring
approach that captures the maximum BML score (0e3) recorded
among all the subregions. To model the number of BMLs, we simply
counted the number of sites in which BML size exceeded 0. Thus,
this variable could take values of 0e9.
Hoffa-Synovitis was assessed at baseline and FU18. The synovitis
scores were quantiﬁed as 0 ¼ “none”, 1 ¼ “mild”, 2 ¼ “moderate”,
3¼ “severe”. Effusionwas captured at baseline and FU18 by a single
variable, which takes the values 0 ¼ “normal, no effusion”,
1 ¼ “small, 33% of maximum potential distention”, 2 ¼ “medium,
2 ¼ 33e66% of maximum potential distention”, and 3 ¼ “large,
3¼>66% of maximum potential distention”.
Testeretest reliability of the above readings was performed on
10% of scans (N ¼ 22) 1 week apart. Reliability for BML size, 0.72,
synovitis 0.66 and effusion 0.61.
Quantitative Cartilage Morphometry. Measurements focused on
the MFTC, because (1) it is the most common site of knee OA28;
(2) changes there are strongly related to BMLs and varus knee
alignment28,31; and (3) we have additional, well-established
measures of joint integrity including JSW and BLOKS30. The
medial tibial (MT) and central weight-bearing medial femoral
(cMF) cartilages were segmented by manual tracing of the total
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laginous joint surface (AC) on a slice-by-slice basis32,33. Seg-
mentation of tAB included all areas of cartilage-covered and
denuded subchondral bone, but not osteophytes34,35. Likewise,
AC segmentation excluded osteophyte cartilage. MT was
segmented throughout all slices that displayed cartilage; anal-
ysis of the femoral condyle was conﬁned to the portion of the
condyles that are displayed without relevant partial volume
effect in coronal images (cMF)36. All segmented data were
quality controlled (QC'd) by one expert, by checking all
segmented slices of each data set, and corrections of the seg-
mentation were performed if necessary.
The same software used for segmentation and QC readings was
used to calculate the size of the tAB, the tAB covered with cartilage
(cAB), the denuded bone area (dAB), the area of the cartilage sur-
face (AC), the mean cartilage thickness across the entire tAB
(ThCtAB), counting all denuded areas as 0 mm cartilage thickness,
the mean cartilage thickness across cAB (ThCcAB), and maximal
cartilage thickness [Fig. 2(a)]32. In addition, subregional measure-
ments were performed by analyzing ThCtAB in central, internal,
external, anterior and posterior subregions of MT, and central in-
ternal and external subregions of cMF, using a method developed
by Wirth et al.37 [Fig. 2(b)].
Statistical analysis
We used a per-protocol analysis to compare change between
groups at FU18 as some participants did not have paired image
acquisitions at baseline and 18 months. X-ray and continuous MRI
outcomes were analyzed using analysis of covariance (ANCOVA)
adjusted for baseline values, BMI, and gender. X-ray was alsoFig. 2. (a) Sagittal magnetic resonance images (MRI) acquired using SPGR sequence. Both im
of the cartilage (magenta ¼ segmentation of the cartilage surface; green ¼ segmentation of
turquoise. The image of the MFTC shows an area of denuded subchondral bone (dAB) in the
Visual display of the medial femorotibial subregions. Posterior view of the femorotibial com
superior view of the tibia (bottom). Color codes for both the femoral and tibial plates
yellow ¼ posterior subregion, turqoise ¼ anterior subregion.adjusted for inter-rim distance. Ordinal logistic regressionwas used
for the ordinal SQ analyses, adjusting for baseline values, BMI and
gender.
For the semi quantitative analysis we used a maximum scoring
approach that captures the maximum BML score (0e3) recorded
among all the subregions. To model the number of BMLs we ﬁtted a
Poisson regression model to the number of subregions with
observed BMLs for each individual to determine a randomization
group effect, adjusting for baseline BMI, gender, and the number of
BMLs reported at baseline. Usingmaximum synovitis scores over all
anatomical locations similar to previous outcomes we performed
an ordinal logistic regression for the maximum synovitis score by
randomization group, adjusting for baseline BMI, gender, and
baseline maximal synovitis score. For effusion due to the small
count of participants with “normal” effusion scores, we collapsed
“normal” and “small” into a single category. We then performed an
ordinal logistic regression for a randomization group effect,
adjusting for gender, baseline BMI, and baseline effusion. All ana-
lyses were performed assuming a Type I error rate of 0.05 using SAS
v9.2 (SAS Institute, Cary, NC).Results
Demographic characteristics (Table I)
A total of 454 personswith amean age 66 years andmean BMI of
33.6 kg m2 were participants in the trial. The three groups were
wellmatched for demographic characteristics including age, gender
and BMI. Similarly there were no major differences in KL grade or
mJSWbetween groups. TheMRI andX-ray subsampleswerebroadly
similar to the overall group for all characteristics (see Table I).ages depict the same slice of the MFTC. The image on the right shows the segmentation
the total area of subchondral bone ¼ tAB) and the ﬁlling between the two surfaces in
weight-bearing aspect of the medial femoral condyle (cMF) and medial tibia (MT). (b)
partment of the knee (middle), inferior view of the weight-bearing femur (top), and
: red ¼ central subregion, green ¼ external subregion, blue ¼ internal subregion,
Table I
Mean (SD) demographic and clinical characteristics of the study participants at baseline
Overall
(N ¼ 454)
Diet only
(N ¼ 152)
Diet and exercise
(N ¼ 152)
Exercise only
(N ¼ 150)
MRI subsample
(n ¼ 98)*
X-ray subsample
(N ¼ 325)
Gender (female N (%)) 325 (72) 108 (71) 109 (72) 108 (72) 72 (73) 240 (74)
Age (mean, SD) yrs 66 (6) 66 (6) 65 (6) 66 (6) 65 (6) 66 (6)
% Non-white 19 16 20 20 16 16
BMI (mean, SD) kg m2 33.6 (3.7) 33.8 (3.6) 33.5 (3.7) 33.5 (3.7) 33.7 (3.8) 33.4 (3.8)
KellgreneLawrence grade
of index knee (% grade 2)
48.7% 48.0% 47.4% 50.7% 42.9% 48.3%
mJSW at baseline (mm) 3.61 (1.92) 3.73 (2.09) 3.44 (1.86) 3.67 (1.80) 3.30 (1.77) 3.61 (1.92)
Mechanical alignment (degrees)y 0.30 (4.39) 0.99 (4.82) 0.28 (4.52) 0.20 (3.74) 0.21 (3.97) 0.33 (4.40)
WOMAC function (range 0e68) 24.2 (10.9) 24.8 (10.4) 24.6 (11.7) 23.1 (10.3) 22.0 (9.9) 23.5 (10.9)
mJSW ¼ minimum joint space width.
* 105 persons had baseline and 18 months MRIs of whom 98 had adequate quality images for the purposes of analysis.
y Negative numbers indicate valgus alignment.
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The mean rate of change in mJSW in the three groups ranged
between 0.18 and 0.28 mm over the 18 months period, with all
of the groups demonstrating progression, andwith no evidence of a
difference between groups.
SQ MRI (Table III)
The odds ratios for BML size indicated no differences between
groups. D and D þ E tended to have lower maximum BML scores at
FU18 than E. For BML lesion count, we observed no signiﬁcant effect
(P ¼ 0.44), and the model-adjusted means appeared to demon-
strate a slightly higher number of lesions in the E group, especially
compared to D. For the maximal synovitis score analysis, we
observed a non-signiﬁcant P value (P ¼ 0.60) with relatively small
averages for all groups using an ordinal logistic regression model.Table II
X-ray JSW change from baseline to 18 months for mJSW and JSWx ¼ 0.225
Diet only Diet &
n 129 136
Baseline mJSW mm(SD) 3.73 (2.09) 3.45 (
Baseline JSW225 mm (SD) 4.64 (2.03) 4.30 (
Change mJSW (95% CI)* 0.28 (0.54, 0.03) 0.27 (
Change JSW225 (95% CI)* 0.35 (0.60, 0.09) 0.23 (
Adj change mJSW (95% CI)y 0.30 (0.54, 0.06) 0.24 (
Adj change JSW225 (95% CI)y 0.39 (0.63, 0.16) 0.21 (
Change weight kg (95% CI) 8.9 (10.3, 7.5) 9.7 (
% Change weight (95% CI) 9.5 (10.9, 8.0) 10.5 (
* Adjusted for baseline BMI, gender and baseline value of outcome.
y Adjusted for baseline BMI, gender and baseline value of outcome and rim quality co
Table III
SQ MRI measures change from baseline to 18 months
Die
No. of observations 33
Maximal BML size Baseline frequency >0 (%)
OR (95% CI)* 0
BML count Baseline mean (SD) 2
Estimate (95% CI)* 0
Maximum synovitis score Baseline frequency >0 (%)
OR (95% CI)* 1
Effusion score Baseline frequency > Normal (%)
OR (95% CI)* 1
Weight Change from BL (kg) (95% CI) 
Change from BL (%) (95% CI) 1
* Adjusted for baseline BMI, gender and baseline value of outcome.For this model, we collapsed categories 2 and 3 at 18 months, given
that only two participants had “severe” synovitis at follow-up. For
effusion the P value for the comparison between groups was not
signiﬁcant (P ¼ 0.72).
Quantitative cartilage morphometry (Table IV)
The quantitative cartilage volume, cartilage thickness and
percent denuded area results were broadly consistent across the
different regions of the knee with no signiﬁcant difference at 18-
months between groups. The Dþ E showed a trend for greater loss.
Effect of malalignment on rate of X-ray progression
One of the challenges in assessing structural modiﬁcation in OA
is that a large proportion of participants often do not progress.
Selecting those with varus malalignment may identify a subgroupexercise Exercise only P value for between
group difference135
1.86) 3.67 (1.80)
1.88) 4.65 (1.87)
0.53, 0.02) 0.18 (0.43, 0.07) 0.81
0.48, 0.03) 0.16 (0.41, 0.09) 0.56
0.47, 0.00) 0.16 (0.40, 0.07) 0.71
0.44, 0.01) 0.15 (0.38, 0.07) 0.29
11.1, 8.3) 1.7 (3.1, 0.2) <0.01
12.0, 9.0) 1.9 (3.3, 0.4) <0.01
ntrol measure.
t only Diet & exercise Exercise only
36 36
29 (88) 33 (92) 32 (89)
.44 (0.15e1.23) 0.70 (0.25e1.95) Referent
.27 (1.51) 1.53 (1.61) 1.51 (1.71)
.20 (0.51 to 0.11) 0.11 (0.40 to 0.18) Referent
18 (55) 20 (56) 17 (47)
.78 (0.53e5.96) 1.10 (0.33e3.70) Referent
32 (97) 59 (98) 35 (97)
.18 (0.47e2.97) 1.46 (0.59e3.61) Referent
9.8 (12.7, 6.9) 10.5 (14.0, 7.0) 1.0 (2.4, 0.3)
0.1 (13.0, 7.1) 11.2 (15.1, 7.4) 1.2 (2.7, 0.2)
Table IV
Quantitative cartilage MRI measures
Description Diet only Diet & exercise Exercise only P value
18 months Change 18 months Change 18 months Change
Mean, SE (95% CI) Mean, SE (%) Mean, SE (95% CI) Mean, SE (%) Mean, SE (95% CI) Mean, SE (%)
Volume of cartilage (mm3) over
area of aggregate MT þ cMF
2583.6, 38.9 (2506.4, 2660.9) 73.1, 38.9 (2.8) 2566.9, 37.6 (2492.2, 2641.5) 89.9, 37.6 (3.4) 2624.4, 36.9 (2551.2, 2697.6) 32.3, 36.9 (1.2) 0.49
Volume of cartilage (mm3)over
area of Media tibia (MT)
1740.9, 25.1 (1691.1, 1790.7) 23.7, 25.1 (1.4) 1727.3, 24.3 (1678.9, 1775.5) 37.4, 24.3 (2.1) 1757.6, 23.6 (1710.7, 1804.4) 7.1, 23.6 (0.4) 0.63
Volume of cartilage (mm3)of
medial fem condyle (cMF)
839.7, 17.5 (804.9, 874.4) 48.9, 17.5 (5.5) 837.3, 16.9 (803.6, 870.9) 51.3, 16.9 (5.8) 865.5, 16.7 (832.3, 898.7) 23.2, 16.7 (2.6) 0.39
Cart thickness (mm) over area
of aggregate MT þ cMF
2.80, 0.05 (2.71, 2.89) 0.10, 0.05 (3.35) 2.77, 0.04 (2.68, 2.86) 0.13, 0.04 (4.34) 2.85, 0.04 (2.76, 2.93) 0.05, 0.04 (1.66) 0.42
Cart thickness (mm) over
area of MT
1.45, 0.02 (1.40, 1.49) 0.02, 0.02 (1.56) 1.43, 0.02 (1.39, 1.47) 0.04, 0.02 (2.65) 1.46, 0.02 (1.42, 1.50) 0.01, 0.02 (0.58) 0.55
Cart thickness (mm) over area
of medial fem condyle (cMF)
1.35, 0.03 (1.30, 1.41) 0.07, 0.03 (5.13) 1.34, 0.03 (1.29, 1.40) 0.08, 0.03 (5.95) 1.39, 0.03 (1.33, 1.44) 0.04, 0.03 (2.66) 0.43
Cart thickness (mm) over area
of central medial tibia
1.86, 0.04 (1.79, 1.93) 0.06, 0.04 (2.89) 1.84, 0.04 (1.77, 1.91) 0.08, 0.04 (4.10) 1.89, 0.03 (1.82, 1.95) 0.03, 0.03 (1.59) 0.59
Cart thickness (mm) over area
of central weight-bearing
medial femur
1.47, 0.04 (1.39, 1.55) 0.10, 0.04 (6.08) 1.43, 0.04 (1.35, 1.51) 0.14, 0.04 (8.66) 1.51, 0.04 (1.43, 1.58) 0.06, 0.04 (3.91) 0.37
Cart thickness (mm) over area
of aggregate cMT & ccMF
3.33, 0.07 (3.20, 3.46) 0.15, 0.07 (4.35) 3.26, 0.07 (3.13, 3.40) 0.22, 0.07 (6.23) 3.39, 0.07 (3.26, 3.52) 0.09, 0.07 (2.67) 0.37
Avg % MT denuded area 7.31, 0.88 (5.56, 9.05) 1.48, 0.88 (25.34) 2566.9, 37.6 (2492.2, 2641.5) 89.9, 37.6 (3.4) 7.10, 0.85 (5.41, 8.80) 1.27, 0.85 (21.81) 0.77
Avg % cMF denuded area 12.38, 1.56 (9.28, 15.48) 2.42, 1.56 (24.36) 1727.3, 24.3 (1678.9, 1775.5) 37.4, 24.3 (2.1) 13.11, 1.55 (10.04, 16.18) 3.16, 1.55 (31.70) 0.82
Bone area (cm2) over area
of aggregate MT þ cMF
2.87, 0.05 (2.78, 2.96) 0.10, 0.05 (3.37) 837.3, 16.9 (803.6, 870.9) 51.3, 16.9 (5.8) 2.93, 0.04 (2.84, 3.02) 0.04, 0.04 (1.49) 0.44
Bone area (cm2) over area of MT 1.46, 0.02 (1.42, 1.50) 0.02, 0.02 (1.51) 2.77, 0.04 (2.68, 2.86) 0.13, 0.04 (4.34) 1.47, 0.02 (1.43, 1.51) 0.01, 0.02 (0.50) 0.63
Bone area (cm2) over area of cMF 1.41, 0.03 (1.35, 1.47) 0.08, 0.03 (5.17) 1.43, 0.02 (1.39, 1.47) 0.04, 0.02 (2.65) 1.46, 0.03 (1.40, 1.51) 0.03, 0.03 (2.32) 0.38
Weight, SD (kg) 87.8, 14.3 (82.4, 93.1) 8.5, 7.6 (11.3, 5.7) 80.4, 13.8 (75.4, 85.4) 10.6, 10.4 (14.3, 6.8) 90.7, 13.3 (86.0, 95.5) 1.2, 3.7 (2.5, 0.1) <0.01
Weight, SD (%) 8.6, 7.7 (11.6, 5.7) 11.4, 11.3 (15.5, 7.3) 1.3, 4.1 (2.8, 0.1) <0.01
D
.J.H
unter
et
al./
O
steoarthritis
and
Cartilage
23
(2015)
1090
e
1098
1095
Fig. 3. Percent changes from baseline (95% CI) for mJSW and MTFC thickness.
D.J. Hunter et al. / Osteoarthritis and Cartilage 23 (2015) 1090e10981096that is more likely to progress. The alignment measures were well
matched between the groups (Table I) with the D group ranging
from 11 to 15, D þ E from 13 to 9.6, and E from 11.3 to 7.3.
The cohort was divided into three broad categories according to
their alignment; <2 ¼ valgus, 2 to þ2 ¼ neutral and >2 ¼ varus.
Bearing in mind that JSW is a measure in the medial compartment
and most of the progression in that compartment will occur in
those that are varus aligned, the analysis focused on that subgroup
of 113 persons with a varus alignment of >2 {range 2.03e15.41}.
With the E group as reference, the Dþ E estimate was 0.15 (SE 0.17)
and D 0.03 (0.17). For the MRI analyses there was no difference
found between groups but it is important to recognize that
the subsample was too small to draw anything meaningful
from these results. Figure 3 compares the main results for change
in mJSW and MFTC (Fig. 3).
Discussion
The results of this trial suggest that intensive diet-induced
weight loss that averaged 10% of body weight over an 18-month
study period, whether through a combination of diet and exercise
or diet alone, does not provide a beneﬁt in terms of knee joint
structure when compared to exercise alone in individuals with
knee OA, despite demonstrating improvements in pain and func-
tion9. It is important to note, however, that the rates of change
(progression) are consistent with prior natural history studies and
as such these interventions are unlikely to be doing harm38,39.
In contrast to our results, previous observational/non-random-
ized studies have raised the possibility that weight loss could be
structure modifying14,18. An Australian observational cohort study
included 78 persons recruited from both non-surgical and surgical
weight loss programs18. They found that weight loss was associated
with improvements in both the quality (improved dGEMRIC index)
and quantity (reduced cartilage thickness losses) of medial articular
cartilage. Interestingly, when comparing our sample with this
observational study the mean loss in medial cartilage thickness in
our samplewas similar to that in those deﬁned as losingweight and
slowing progression in the other study18.
Richette et al. studied 44 persons undergoing gastric surgery
with painful knee OA14. Weight loss resulted in a signiﬁcant in-
crease in N-terminal propeptide of type IIA collagen levels (þ32%;
P ¼ 0.002), a biomarker of cartilage synthesis, and a signiﬁcantdecrease in cartilage oligomeric matrix protein (COMP) (36%;
P < 0.001), a biomarker of cartilage degradation. These results
suggest a favorable effect of weight loss on cartilage turnover.
There are a number of differences from these studies and our
own. As distinct from these uncontrolled studies, we included an
active comparator that may itself have structure modifying effects.
The weight loss in these studies was largely gained from bariatric
surgery, which resulted in ~20% weight loss; substantially more
than our mean weight loss of 10%. Importantly, this is an area
currently under investigation and we await with great interest the
results of other studies with similar objectives to our own40.
Prior radiographic studies also afford a useful historical com-
parison with the rates of change we found in this study. Some
recent systematic reviews demonstrate that the mean rate of
annual narrowing is about 0.15 mm/year38,41, but importantly
greatly varies between studies due to length of follow-up, method
of radiographic acquisition, measurement method and radio-
graphic status at time of recruitment. Based upon this literature,
for a study of 18 months duration if structural progression is linear
one would expect JSW loss of 0.225 mm. All of the groups in the
IDEA trial lost JSW at approximately the rate that would be ex-
pected compared to the natural history changes. Intriguingly, the
small subsample of persons with varus malalignment who are at
greatest risk of medial femorotibial progression showed the
greatest beneﬁt in the combination diet and exercise group. It is
difﬁcult to make too much of this result on a small sample and
warrants conﬁrmation in future larger studies. Given variability in
the magnitude and timing of weight loss, we are planning sec-
ondary analyses to look further at questions such as the dose
response relationship between the magnitude of weight loss and
structural change.
The inherent appeal in conducting MRI measurements are
suggestions from previous data that MRI measures are more
responsive35,39 and that the relation of structure to symptoms may
be stronger42. The results of SQ MRI analyses show trends sug-
gestive of beneﬁt for both of the dietary groups (D and D þ E);
however, larger studies will be required to clarify the effect of
weight loss is on joint structure.
There are a number of limitations of this study that warrant
discussion. The lack of a control group that received no “active”
intervention makes disentangling treatment effects challenging. It
is quite plausible that the exercise alone group redeemed some
D.J. Hunter et al. / Osteoarthritis and Cartilage 23 (2015) 1090e1098 1097beneﬁt from a joint structure perspective and hence dissecting the
beneﬁt from the dietary arms in this study was problematic. The
number of persons who had an MRI acquired during the study was
small, limiting our ability to make important between group dis-
tinctions based upon the size and subsequent power of the ana-
lyses. The lack of contrast administration also reduced our ability to
detect more subtle changes in synovitis43.
In summary, in a per-protocol analysis there was no statistically
signiﬁcant difference in the rate of progression in X-ray or quan-
titative MRI for persons undergoing intensive weight loss through
diet, with and without exercise compared to exercise alone despite
signiﬁcant improvements in pain, function, and in biomechanical
and inﬂammatory pathways towards OA in the diet groups9. We
observed the expected amount of progression in JSW in each group,
hence our interventions are unlikely to have caused more rapid
progression. This ﬁnding is important given the potential concern
of promoting joint damage with weight bearing exercise in over-
weight and obese adults who are not also losing weight. The
ﬁndings do not denigrate the important symptomatic ﬁndings in
the same trial and the important implications they have for this
pressing public health issue of growing obesity and knee OA
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